In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an ...

Valued at a market cap of $9.6 billion, Cambridge, Massachusetts-based Moderna, Inc. (MRNA) is a biotechnology company that ...

Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

As the 2020 pandemic became a distant memory and millions of Americans returned back to their old lives, some were left ...

US mRNA specialist Moderna (Nasdaq: MRNA) has announced that its manufacturing facility in the UK has been granted a manufacturer’s license by the Medicines and Healthcare products Regulatory Agency ...

The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating ...

Shares of several vaccine makers soared after reports suggest that the Biden administration is in discussions with Moderna MRNA and Pfizer PFE to set up a possible vaccine program aimed at ...

The update includes Pfizer Inc.’s (NYSE:PFE) Abrysvo (Respiratory Syncyt The Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE) to develop bird flu ...